Accession | ARO:3003780 |
Definition | A heterocyclic antibiotic that targets mutant gyrA (type II topoisomerase) containing an S84L substitution, counteracting acquired quinolone resistance. It is effective against quinolone-resistant Gram-positive bacteria including S. aureus and E. faecalis. Due to its ability to counteract quinolone resistance by targeting the mutant form of the gyrA protein, it is classified as a reverse antibiotic (RA). |
Drug Class | nybomycin-like antibiotic |
Classification | 2 ontology terms | Show |
Parent Term(s) | 1 ontology terms | Show + nybomycin-like antibiotic [Drug Class] |
Sub-Term(s) | 1 ontology terms | Show + fluoroquinolone resistant gyrA [AMR Gene Family] targeted_by_antibiotic |
Publications | Strelitz F, et al. 1955. Proc. Natl. Acad. Sci. U.S.A. 41(9):620-4 NYBOMYCIN, A NEW ANTIBIOTIC WITH ANTIPHAGE AND ANTIBACTERIAL PROPERTIES. (PMID 16589716) Hiramatsu K, et al. 2012. Int. J. Antimicrob. Agents 39(6):478-85 Curing bacteria of antibiotic resistance: reverse antibiotics, a novel class of antibiotics in nature. (PMID 22534508) |